EICHORPublic-registry site landscape for NCT04154072, “A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease”, a Parkinson Disease study sponsored by Neuraly, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04154072 (registry record) |
| Study title | A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease |
| Official title | Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of 36 Weeks of Treatment With NLY01 in Early-stage Parkinson's Disease |
| Sponsor | Neuraly, Inc. |
| Condition(s) | Parkinson Disease |
| Phase | PHASE2 |
| Listed sites | 61 |
| Site countries | United States, Canada |
Patient-friendly overview of this study: eichor.com/study/NCT04154072.
Eichor generates a preliminary site-risk snapshot for NCT04154072 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Parkinson Disease trials
More from Neuraly, Inc.
← Eichor home · All tracked trials · Parkinson Disease studies · Weekly briefs
